AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
My Activity
EN
Login
EN
Surge Analysis
/
Protagenic Therapeutics Inc.
/
2026-05-08
▲ SURGE
Protagenic Therapeutics Inc.
+36.2%
PTIX
NASDAQ
Healthcare
2026-05-08
0.79
Close
0.58
Prev Close
+36.21%
Change
2.3x
Vol Ratio
Why It Surged
2026년 4월 7일, Protagenic Therapeutics는 최고재무책임자(CFO)의 해임을 발표했습니다.
·
2026년 4월 7일, Protagenic Therapeutics는 최고재무책임자(CFO)의 해임을 발표했습니다.
Related News
Protagenic Therapeutics Announces Termination of Chief Financial Officer
Tipranks
2026-04-07
Protalix BioTherapeutics Shares Fall After Swing to 2025 Loss
Marketwatch
2026-03-18
Protagonist Therapeutics Soars as FDA Approves ICOTYDE for Plaque Psoriasis, Triggers $50M Milestone
Marketbeat
2026-03-21
Leerink Partners Maintains Outperform on Protagonist Therapeutics, Raises Price Target to $110 - Protagonist Therapeutics (NASDAQ:PTGX)
Benzinga
2026-03-19
Perspective Therapeutics Highlights Encouraging Interim Neuroendocrine Tumor Data
Theglobeandmail
2026-04-21
Technical Analysis
No technical analysis available.
View Company
Back to Surge Stocks
Home
Chat
Portfolio
Activity
Menu
Protagenic Therapeutics Inc. Surged +36.2% on 2026-05-08 — Analysis | Alpha Lenz